Interaction of human stefin B in the prefibrillar oligomeric form with membranes: Correlation with cellular toxicity

FEBS Journal

Volumn 272, Issue 12, 2005, Pages 3042-3051

  Anderluh, Gregor ^a   Gutierrez Aguirre, Ion ^a   Rabzelj, Sabina ^b   Čeru, Slavko ^b   Kopitar Jerala, Nataša ^b   Maček, Peter ^a   Turk, Vito ^b   Žerovnik, Eva ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Amyloid toxins; Conformational disease; Cystatins; Lipid binding; Prefibrillar oligomers

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID; AMYLOID BETA PROTEIN; BETA 2 MICROGLOBULIN; CALCEIN; DIOLEOYLPHOSPHATIDYLCHOLINE; GLYCEROL DERIVATIVE; LIGAND; OLIGOMER; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PRION PROTEIN; STEFIN A; STEFIN B; TOXIC SUBSTANCE;

ACIDITY; ALZHEIMER DISEASE; ARTICLE; CHANNEL GATING; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; LIPID MEMBRANE; MODEL; MONOLAYER CULTURE; NEUROBLASTOMA CELL; PRESSURE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; SURFACE PROPERTY;

CELL MEMBRANE; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; FLUORESCEINS; HUMANS; LIPID BILAYERS; MEMBRANE LIPIDS; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; PERMEABILITY; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; SURFACE PROPERTIES; TETRAZOLIUM SALTS; THIAZOLES; TOXICITY TESTS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 21344453979     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04717.x     Document Type: Article

References (49)

1. Goedert M, Spillantini MG & Davies SW (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8, 619-632.
2. Rochet JC & Lansbury PT Jr (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10, 60-68.
3. Ohnishi S & Takano K (2004) Amyloid fibrils from the viewpoint of protein folding. Cell Mol Life Sci 61, 511-524.
4. Guijarro JI, Sunde M, Jones JA, Campbell ID & Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 95, 4224-4228.
5. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24, 329-332.
6. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM & Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
7. Sirangelo I, Malmo C, Iannuzzi C, Mezzogiorno A, Bianco MR, Papa M & Irace G (2004) Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F. J Biol Chem 279, 13183-13189.
8. Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM & Stefani M (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 279, 31374-31382.
9. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW & Glabe CG (2003) Common structure of soluble amyloid oligomers implies common pathology. Science 300, 487-489.
10. Kagan BL, Hirakura Y, Azimov R, Azimova R & Lin MC (2002) The channel hypothesis of Alzheimer's disease: current status. Peptides 23, 1311-1315.
11. Yip CM, Elton EA, Darabie AA, Morrison MR & McLaurin J (2001) Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol 311, 723-734.
12. Turk B, Turk D & Salvesen GS (2002) Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 8, 1623-1637.
13. Kagitani-Shimono K, Imai K, Okamoto N, Ono J & Okiida S (2002) Unverricht-Lundborg disease with cystatin B gene abnormalities. Pediatr Neurol 26, 55-60.
14. Jensson O, Palsdottir A, Thorsteinsson L, Arnason A, Abrahamson M, Olafsson I & Grubb A (1990) Cystatin C mutation causing amyloid angiopathy and brain hemorrhage. Biol Chem Hoppe Seyler 371 (Suppl.), 229-232.
15. Žerovnik E, Pompe-Novak M, Škarabot M, Ravnikar M, Muševič I & Turk V (2002) Human stefin B readily forms amyloid fibrils in vitro. Biochim Biophys Acta 1594, 1-5.
16. Žerovnik E, Turk V & Waltho JP (2002) Amyloid fibril formation by human stefin B: influence of the initial pH-induced intermediate state. Biochem Soc Trans 30, 543-547.
17. Žerovnik E, Zavašnik-Bergant V, Kopitar-Jerala N, Pompe-Novak M, Škarabot M, Goldie K, Ravnikar M, Muševič I & Turk V (2002) Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A. Biol Chem 383, 859-863.
18. Jenko S, Škarabot M, Kenig M, Gunčar G, Muševič I, Turk D & Žerovnik E (2004) Different propensity to form amyloid fibrils by two homologous proteins - Human stefins A and B: searching for an explanation. Proteins 55, 417-425.
19. Žerovnik E, Jerala R, Kroon-Žitko L, Turk V & Lohner K (1997) Characterization of the equilibrium intermediates in acid denaturation of human stefin B. Eur J Biochem 245, 364-372.
20. Žerovnik E, Jerala R, Kroon-Žitko L, Pain RH & Turk V (1992) Intermediates in denaturation of a small globular protein, recombinant human stefin B. J Biol Chem 267, 9041-9046.
21. Demel RA, Geurts van Kessel WS, Zwaal RF, Roelofsen B & van Deenen LL (1975) Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim Biophys Acta 406, 97-107.
22. Cho W, Bittova L & Stahelin RV (2001) Membrane binding assays for peripheral proteins. Anal Biochem 296, 153-161.
23. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ & Teplow DB (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274, 25945-25952.
24. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB & Selkoe DJ (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884.
25. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6553.
26. Klein WL (2002) Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41, 345-352. Review.
27. Arispe N, Pollard HB & Rojas E (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein (Abeta P-(1-40)) in bilayer membranes. Proc Natl Acad Sci USA 90, 10573-10577.
28. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc Natl Acad Sci USA 93, 1710-1715.
29. 2+-channel hypothesis for neuronal death in AD. Mol Cell Biochem 140, 29-135.
30. Pollard HB, Rojas E & Arispe N (1998) Ion channels formed by amyloid β-protein (A-P(1-40)). Pharmacology and therapeutic implications for Alzheimer's disease. In Ion Channel Pharmacology (Soria VB & Ceña V, eds), Chapter 6. Oxford University Press, Oxford.
31. Kourie JI, Henry CL & Farrelly P (2001) Diversity of amyloid beta protein fragment [1-40]-formed channels. Cell Mol Neurobiol 21, 255-284.
32. Mirzabekov T, Lin M-C & Kagan BL (1988-92) (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 270.
33. Hirakura Y & Kagan BL (2001) Pore formation by microglobulin. A mechanism for the pathogenesis of dialysis associated amyloidosis. Amyloid 8, 94-100.
34. Lin M-C, Mirzabekov T & Kagan BL (1997) Channel formation by a neurotoxic prion protein fragment. J Biol Chem 272, 44-47.
35. Kourie JI & Culverson A (2000) Prion fragment PrP (106-126) forms distinct channel types. J Neurosci Res 62, 120-133.
36. Kawahara M, Kuroda Y, Arispe N & Rojas E (2000) Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275, 14077-14083.
37. Jo E, McLaurin JA, Yip CM, St. George-Hyslop P, Frazer PE (2000) α-Synuclein membrane interactions and lipid specificity. J Biol Chem 44, 34328-34334.
38. Walsh DM & Selkoe DJ (2004) Oligomers in the brain: emerging role of soluble protein aggregates in neurodegeneration. Protein Peptide Lett 11, 213-228.
39. Cho W (2001) Membrane targeting by C1 and C2 domains. J Biol Chem 276, 32407-32410.
40. Yu JW & Lemmon MA (2003) Genome-wide analysis of signaling domain function. Curr Opin Chem Biol 7, 103-109.
41. Hong Q, Gutierrez-Aguirre I, Barlic A, Malovrh P, Kristan K, Podlesek Z, Macek P, Turk D, Gonzalez-Manas JM, Lakey JH et al. (2002) Two-step membrane binding by equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. J Biol Chem 277, 41916-41924.
42. Ramachandran R, Heuck AP, Tweten RK & Johnson AE (2002) Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat Struct Biol 9, 823-827.
43. Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, Kessler JC & Lansbury PT Jr (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819.
44. Anderluh G & Maček P (2002) Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria). Toxicon 40, 111-124.
45. Tweten RK, Parker MW & Johnson AE (2001) The cholesterol-dependent cytolysins. Curr Top Microbiol Immunol 257, 15-33.
46. Zhao H, Jutila A, Nurminen T, Wickstrom SA, Keski-Oja J & Kinnunen PKJ (2005) Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Biochemistry 44, 2857-2863.
47. Jerala R, Trstenjak M, Lenarčič B & Turk V (1988) Cloning a synthetic gene for human stefin B and its expression in E. coli. FEBS Lett 239, 41-44.
48. Jerala R, Kroon-Žitko L & Turk V (1994) Improved expression and evaluation of polyethyleneimine precipitation in isolation of recombinant cysteine proteinase inhibitor stefin B. Protein Expr Purif 5, 65-69.
49. MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK & Hu L (1991) Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim Biophys Acta 1061, 297-303.